← FDA Drug Approvals (Drugs@FDA)

POTASSIUM CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2017-09-11

Drug application

FDA Application #

ANDA206813

Application type

Abbreviated New Drug Application (Generic)

Brand name

POTASSIUM CITRATE

Generic name

POTASSIUM CITRATE

Active ingredients

POTASSIUM CITRATE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

STRIDES PHARMA

Manufacturer

Strides Pharma Inc.

First approval

2017-09-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown